Please verify that you are a Healthcare Professional. Register for complete access to all the content!
Trial compares 1% Terbinafine vs 1% Clotrimazole C...
A randomized controlled trial showed that for Tinea pedis (athletic foot) management, 1 week Terbinafine twice a day is as effective as 4 weeks C...
3 minStudy assesses efficacy of ketorolac for treatment...
In people presenting with migraine headache, ketorolac might have similar effectiveness when compared to phenothiazines and metoclopramide for mi...
3 minTirzepatide injection gets FDA approval for chroni...
According to the notification published on 8 Nov 2023, the United States Food and Drug Administration (US-FDA) has authorized Tirzepatide injecti...
4 minStudy reveals the effect of Isotretinoin on menstr...
Novel findings from a recent prospective observational study shed light on the impact of oral intake of Isotretinoin on menstrual cycles among ac...
1 minIs alcohol safe for rheumatoid arthritis patients...
Rheumatoid Arthritis (RA) patients taking Methotrexate (MTX) are often advised to decrease their alcohol intake due to the increased risk of hepa...
2 minUnderstanding bleeding patterns associated with ea...
A recent study published in the Maternal-Fetal Medicine Journal found that terminated bleeding after 2 weeks is a predictive indicator for effe...
2 minDoes exercise induce GERD or relieve acid reflux?...
Different factors are accountable for the impact of exercise or physical activity on the onset of gastroesophageal reflux disease (GERD), a sessi...
3 minGERD Symptoms: Could Intermittent Fasting Help?
A study published in the "Journal of Clinical Gastroenterology" showed symptomatic relief in gastroesophageal reflux disease (GERD) sym...
2 minClinical features of a headache or facial pain bef...
Herpes zoster (HZ) also known as shingles is a painful, blistering skin eruption in a dermatomal distribution. When the patients are suffering fr...
3 minLactation duration linked to blood pressure reduct...
A strong association exists between lactation duration and substantial reductions in both systolic and diastolic blood pressure (BP) a year after...
3 minRabeprazole and vonoprazan dual therapies match quadruple therapy...
Dual therapy with rabeprazole or vonoprazan achieves similar H. pylori eradication rates as quadruple therapy, while offering better symptom reli...
Bempedoic acid shows strong LDL-C lowering effects in hypercholes...
Bempedoic acid (180 mg/day) markedly reduces LDL-C levels and improves overall lipid profiles in hypercholesterolemia patients who are unable to...
Obesity limits effectiveness of febuxostat in male gout patients
Obesity, but not overweight, substantially impairs response to febuxostat-based urate-lowering therapy in men with gout.
New study finds synthetic oxytocin may protect against postpartum...
Synthetic oxytocin during labor reduces postpartum depression incidence among new mothers.
Low-dose amitriptyline improves TMD-related pain and quality of l...
Patients with chronic temporomandibular disorders experience substantial pain relief and better quality of life with low-dose amitriptyline.
Headache treatment lowers blood pressure in most migraine patient...
In patients without diagnosed hypertension, treating migraine effectively reduces both pain and elevated blood pressure—often eliminating t...
New FDA-approved medication for hemophilia offers dosing every 2...
Fitusiran, a groundbreaking treatment for hemophilia A and B is approved by the FDA, offering a less frequent dosing schedule of once every 2 mon...
FDA greenlights dupilumab for adolescents and adults with chronic...
Dupilumab has received FDA approval for chronic spontaneous urticaria in patients aged 12 years and older, expanding its use to over 300,000 U.S....
Fresh from the FDA: First-ever non-opioid for acute pain is now O...
Suzetrigine is a crucial non-opioid alternative for managing acute pain, helping to reduce reliance on opioids while ensuring effective patient r...
Pioneering antidiabetic leads as first FDA-approved therapy for o...
Tirzepatide improves sleep quality, promotes weight loss, and overall health in overweight people with obstructive sleep apnea.
Russia’s N protein-based vaccine emerges as strong contender in g...
N protein-based COVID-19 vaccine shows 85.2% efficacy and a strong safety profile, offering a crucial alternative for patients struggling with tr...
Updated non-mRNA COVID vaccine receives FDA approval for enhanced...
The updated non-mRNA COVID-19 vaccine offers targeted protection against Omicron variants for individuals 12+ with enhanced safety and efficacy.
This website uses cookies to help us give you the best experience when you visit.
By using this website you consent to our use of cookies. For more information please review our cookie policy.